Target intelligence / Profile preview

Cellular macromolecules (DNA, proteins, and lipids) (ROS-mediated damage)

Target
ROS-mediated damage
Molecular classification
Other
01

Overview

Cellular macromolecules via reactive oxygen species-mediated damage refers to the collective oxidative degradation of DNA, proteins, and lipids caused by reactive oxygen species (ROS) such as superoxide, hydrogen peroxide, and hydroxyl radicals (Pizzino et al., 2017, Oxidative Medicine and Cellular Longevity). ROS are generated during normal mitochondrial respiration or by enzymes like NADPH oxidase, but excessive levels lead to oxidative stress, causing mutations in DNA, misfolding of proteins, and lipid peroxidation of membranes (Sies et al., 2017, Nature Reviews Molecular Cell Biology). This damage is a central driver in the pathogenesis of cancer, neurodegenerative disorders like Alzheimer's, and cardiovascular diseases (Schieber & Chandel, 2014, Current Biology). Pharmacological intervention typically involves antioxidants (e.g., N-acetylcysteine) or scavengers (e.g., Edaravone) that neutralize ROS before they can interact with these macromolecules (Forman & Zhang, 2021, Free Radical Biology and Medicine). However, because ROS also function as essential signaling molecules in processes like immune response and cell differentiation, non-specific targeting can lead to significant safety concerns and therapeutic failure (Harris & DeNicola, 2020, Nature Reviews Cancer).

Other names
Oxidative stress targetsReactive oxygen species targetsMacromolecular oxidative damageROS-induced damage
02

Mechanism of action

Neutralization of reactive oxygen species (ROS) through scavenging, donation of electrons to stabilize free radicals, or induction of endogenous antioxidant enzymes to prevent oxidative modification of cellular components.

03

Biological functions

Cell deathApoptosisSignal transductionOxidative stress responseMetabolism
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationAging
05

Safety considerations

Disruption of physiological redox signalingPotential pro-oxidant activity at high concentrationsLack of specificity for pathological versus physiological ROSPoor clinical efficacy of non-targeted antioxidants
06

Interacting drugs

N-acetylcysteine

6 more in the full profile.

07

Biomarkers

8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)Protein carbonyl content4-Hydroxynonenal (4-HNE)

Beyond the preview

Go deeper on Cellular macromolecules (DNA, proteins, and lipids) (ROS-mediated damage).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular macromolecules (DNA, proteins, and lipids) (ROS-mediated damage).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call